MetaADEDB 2.0 @ LMMD
Barium Sulfate
(TZCXTZWJZNENPQ-UHFFFAOYSA-L)
Structure
SMILES
[O-]S(=O)(=O)[O-].[Ba+2]
Type(s)
Approved
ATC code(s)
V08BA02
Molecular Formula:
BaO4S
Molecular Weight:
233.390
Log P:
-0.2572
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
88.64
CAS Number(s):
7727-43-7; 8054-35-1; 13462-86-7
Synonym(s)
1.
Barium Sulfate
2.
Barite
3.
Baritop
4.
Barium Sulfate (2:1)
5.
E-Z-CAT
6.
Micropaque Oral
7.
E Z CAT
8.
EZCAT
9.
Sulfate, Barium
External Link(s)
MeSHC029044
D001466
PubChem Compound517271
139207729
24414
ChEBI133326
CHEMBLCHEMBL2105897
DrugBankDB11150
KEGGdr:D02052
Therapeutic Target DatabaseD0T5DE
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1No adverse eventFAERS: 27US FAERS
2AppendicitisFAERS: 12US FAERS
3Product physical consistency issueFAERS: 8US FAERS
4Abdominal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
5ExtravasationFAERS: 7US FAERS
6Product physical issueFAERS: 7US FAERS
7ConstipationFAERS: 5US FAERS
8Contrast media reactionFAERS: 5US FAERS
9Drug ineffectiveFAERS: 5US FAERS
10Incorrect route of drug administrationFAERS: 5US FAERS
11VomitingFAERS: 5US FAERS
12Barium impactionFAERS: 4US FAERS
13Cardiac ArrestFAERS: 4US FAERS
14Expired product administeredFAERS: 4US FAERS
15Foreign body aspirationFAERS: 4US FAERS
16Intestinal ObstructionFAERS: 4US FAERS
17Product preparation errorFAERS: 4US FAERS
18Product taste abnormalFAERS: 4US FAERS
19PruritusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Throat irritationFAERS: 4US FAERS
21Abdominal tendernessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Accidental exposure to productFAERS: 3US FAERS
23Blood sodium decreasedFAERS: 3US FAERS
24Burning sensationFAERS: 3US FAERS
25DermatomyositisFAERS: 3US FAERS
26Product container seal issueFAERS: 3US FAERS
27Product contamination physicalFAERS: 3US FAERS
28Septic ShockFAERS: 3US FAERS
29ShockFAERS: 3US FAERS
30AngioedemaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
31ChillsFAERS: 2US FAERS
32DehydrationFAERS: 2US FAERS
33Drug clearance decreasedFAERS: 2US FAERS
34Duodenal perforationFAERS: 2US FAERS
35GranulomaFAERS: 2US FAERS
36HypersensitivityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
37HypoxiaFAERS: 2US FAERS
38Iatrogenic injuryFAERS: 2US FAERS
39IleusFAERS: 2US FAERS
40Liquid product physical issueFAERS: 2US FAERS
41Medication ErrorFAERS: 2US FAERS
42MyalgiaFAERS: 2US FAERS
43PeritonitisFAERS: 2US FAERS
44PoisoningFAERS: 2US FAERS
45Poor quality drug administeredFAERS: 2US FAERS
46Procedural complicationFAERS: 2US FAERS
47Product label confusionFAERS: 2US FAERS
48Pulmonary EmbolismFAERS: 2US FAERS
49Rash erythematousFAERS: 2US FAERS
50Respiratory FailureFAERS: 2US FAERS
51Respiratory distressFAERS: 2US FAERS
52SepsisFAERS: 2US FAERS
53UrticariaFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
54Water IntoxicationFAERS: 2US FAERS
55WheezingFAERS: 2US FAERS
56Wrong drug administeredFAERS: 2US FAERS
57Abdominal AbscessFAERS: 1US FAERS
58Abdominal discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Abdominal massFAERS: 1US FAERS
60AbscessFAERS: 1US FAERS
61Acute kidney injuryFAERS: 1US FAERS
62Adverse eventFAERS: 1US FAERS
63Back PainFAERS: 1US FAERS
64Blood creatinine increasedFAERS: 1US FAERS
65Blood glucose increasedFAERS: 1US FAERS
66Blood urea increasedFAERS: 1US FAERS
67Blood urine presentFAERS: 1US FAERS
68BronchospasmFAERS: 1US FAERS
69Catheter sepsisFAERS: 1US FAERS
70Colonic StenosisFAERS: 1US FAERS
71Deep Vein ThrombosisFAERS: 1US FAERS
72Diffuse alveolar damageFAERS: 1US FAERS
73DiscomfortFAERS: 1US FAERS
74Drug administration errorFAERS: 1US FAERS
75Drug screen positiveFAERS: 1US FAERS
76DysgeusiaFAERS: 1US FAERS
77Feeling abnormalFAERS: 1US FAERS
78FibrosisFAERS: 1US FAERS
79FlatulenceFAERS: 1US FAERS
80FlushingFAERS: 1US FAERS
81Gastrointestinal PainFAERS: 1US FAERS
82Gastrointestinal perforationFAERS: 1US FAERS
83Gastrointestinal stoma complicationFAERS: 1US FAERS
84General physical health deteriorationFAERS: 1US FAERS
85HypotensionFAERS: 1US FAERS
86HypoventilationFAERS: 1US FAERS
87Iatrogenic infectionFAERS: 1US FAERS
88Incorrect route of product administrationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Intestinal PerforationFAERS: 1US FAERS
90Intubation complicationFAERS: 1US FAERS
91LeukocytosisFAERS: 1US FAERS
92Lip erythemaFAERS: 1US FAERS
93Lip exfoliationFAERS: 1US FAERS
94Liver AbscessFAERS: 1US FAERS
95MalnutritionFAERS: 1US FAERS
96Manufacturing production issueFAERS: 1US FAERS
97Medication residue presentFAERS: 1US FAERS
98Metabolic acidosisFAERS: 1US FAERS
99Myocardial InfarctionFAERS: 1US FAERS
100Neonatal aspirationFAERS: 1US FAERS
101Occupational exposure to productFAERS: 1US FAERS
102Oropharyngeal painFAERS: 1US FAERS
103PainFAERS: 1US FAERS
104PeriostitisFAERS: 1US FAERS
105PleurisyFAERS: 1US FAERS
106Poor personal hygieneFAERS: 1US FAERS
107Post procedural complicationFAERS: 1US FAERS
108Procedural site reactionFAERS: 1US FAERS
109Product container issueFAERS: 1US FAERS
110Product formulation issueFAERS: 1US FAERS
111Product quality issueFAERS: 1US FAERS
112Product reconstitution quality issueFAERS: 1US FAERS
113Product storage errorFAERS: 1US FAERS
114RegurgitationFAERS: 1US FAERS
115Respiratory DepressionFAERS: 1US FAERS
116Respiratory arrestFAERS: 1US FAERS
117Retinal DetachmentFAERS: 1US FAERS
118RhabdomyolysisFAERS: 1US FAERS
119SigmoiditisFAERS: 1US FAERS
120SomnolenceFAERS: 1US FAERS
121StomatitisFAERS: 1US FAERS
122ThrombophlebitisFAERS: 1US FAERS
123TremorFAERS: 1US FAERS
124Vulvovaginal painFAERS: 1US FAERS
125Weight decreasedFAERS: 1US FAERS
126Wrong technique in product usage processFAERS: 1US FAERS
127ErythemaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.